FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology. Invention is presented by Influenzavirus A, subtype H9N2, strain A/HK/HK/6:2/2016 (H9N2), deposited in the State Collection of Viruses of FGBU FNIECEM of N. F. Gamalea of Ministry of Health of Russia with No. 2884, for production of inactivated and live influenza vaccines against potentially pandemic influenza virus A/H9N2.
EFFECT: invention makes it possible to intensify protective actions of vaccines against pandemic influenza A virus subtype H9.
1 cl, 3 dwg, 5 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
STRAIN OF INFLUENZA VIRUS A/UNL/HK/2:6/2017 (H5N8) FOR PRODUCING INACTIVATED AND LIVE INFLUENZA VACCINES | 2018 |
|
RU2702834C1 |
A/SHANGHAI/HK/6:2/2013 (H7N9) INFLUENZA VIRUS STRAIN FOR THE PRODUCTION OF INACTIVATED AND LIVING INFLUENZA VACCINES | 2017 |
|
RU2664460C1 |
STRAIN OF INFLUENZA A/JAPAN/GK/6:2/2014 (H2N2) FOR PRODUCTION OF INACTIVE AND LIVE INFLUENZA VACCINES | 2017 |
|
RU2644670C1 |
INFLUENZA VIRUS STRAIN A/Hongkong/1/68/162/35 (H3N2) - UNIVERSAL DONOR OF INTERNAL GENES FOR REASSORTANTS, AND REASSORTANT STRAINS A/SPB/GK/09 (H1N1) AND A/HK/Astana/6:2/2010 (H5N1) PREPARED THEREOF | 2011 |
|
RU2511431C2 |
INFLUENZA VIRUS STRAIN FOR PRODUCING LIVE AND INACTIVATED INFLUENZA VACCINE | 2011 |
|
RU2464309C1 |
RECOMBINANT INFLUENZA VIRUS STRAIN A/PR8/HK-NS80E85A, EXPRESSING FRAGMENTS OF ESAT-6 AND AG85A MYCOBACTERIUM TUBERCULOSIS ANTIGENS, TO OBTAIN TUBERCULOSIS VECTORED VACCINE | 2018 |
|
RU2678175C1 |
STRAIN OF INFLUENZA VIRUS A/17/MALLARD/NETHERLANDS/00/95(H7N3) FOR PRODUCTION OF LIVE AND INACTIVATED INFLUENZA VACCINES | 2012 |
|
RU2507256C2 |
STRAIN OF INFLUENZA VIRUS GKV 2389 FOR PRODUCTION OF LIVING INTRANASAL AND INACTIVATED INFLUENZA VACCINE | 2006 |
|
RU2318871C1 |
REASSORTANT INFLUENZA VIRUS STRAIN RN9/13-HUMAN A(H6N9) FOR NEURAMINIDASE ANTIBODY ASSAY IN INFLUENZA INFECTION AND VACCINATION | 2014 |
|
RU2587629C1 |
VACCINE INFLUENZA VIRUS STRAIN A(H3N2)-A/8/Perth/16/2009 FOR PRODUCTION OF INACTIVATED INFLUENZA VACCINE | 2010 |
|
RU2458124C2 |
Authors
Dates
2019-10-11—Published
2018-12-21—Filed